Paliperidone palmitate use in pregnancy in a woman with schizophrenia-Reference-Cited by-同舟云学术

Paliperidone palmitate use in pregnancy in a woman with schizophrenia

Published:2015-01-21 Issue:5 Volume:18 Page:739-740
ISSN:1434-1816
Container-title:Archives of Women's Mental Health
language:en
Short-container-title:Arch Womens Ment Health

Author:

Özdemir Aslı Karadağ,Pak Şima Ceren,Canan Fatih,Geçici Ömer,Kuloğlu Murat,Gücer Mustafa Kadri

Publisher

Springer Science and Business Media LLC

Subject

Psychiatry and Mental health,Obstetrics and Gynecology

Link

http://link.springer.com/content/pdf/10.1007/s00737-014-0496-6.pdf

Reference5 articles.

1. Coverdale JH, Turbort SH, Roberts H (1997) Family planning needs and STD risk behaviours of female psychiatric outpatients. Br J Psychiatry 171:69–72

2. Kim SW, Kim KM, Kim JM, Shin IS, Shin HY, Yang SJ, Yoon JS (2007) Use of long-acting injectable risperidone before and throughout pregnancy in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 31:543–545

3. Kramer M, Litman R, Hough D, Lane R, Lim P, Liu Y, Eerdekens M (2010) Paliperidone palmitate, a potential long-acting treatment for patients with schizophrenia. Results of a randomized, double-blind, placebo-controlled efficacy and safety study. Int J Neuropsychopharmacol 13:635–647

4. Miller LJ, Finnrerty M (1996) Sexuality, pregnancy, and childbearing among women with schizophrenia-spectrum disorders. Hosp Community Psychiatry 47:502–506

5. Nasrallah HA (2007) The case for long-acting antipsychotic agents in the post-CATIE era. Acta Psychiatr Scand 115:260–267

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Outcomes of long-acting injectable antipsychotics use in pregnancy: A literature review;World Journal of Psychiatry;2024-04-19

2. Long-acting antipsychotic treatments: focus on women with schizophrenia;Therapeutic Advances in Psychopharmacology;2024-01

3. Concepts for selection and utilization of psychiatric medications in pregnancy;Mental Health Clinician;2023-12-01

4. Cumulative Clinical Experience of the Use of Paliperidone Palmitate 3-Monthly Long-Acting Injection in the Treatment of Schizophrenia: A Critical Appraisal;Drug, Healthcare and Patient Safety;2023-09

5. Invega Hafyera (Paliperidone Palmitate): Extended-Release Injectable Suspension for Patients With Schizophrenia;Journal of Pharmacy Technology;2023-03-16